Related Experiment Video
Updated: Jul 30, 2025

11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.4K
Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing
Sean T Glenn1, Phillip M Galbo1, Jesse D Luce2
1Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Oncotarget
|May 12, 2023
Summary
This study developed an automated method using next-generation sequencing (NGS) to accurately detect B and T cell clonality, improving diagnosis of lymphoproliferative disorders.
Area of Science:
- Immunology
- Molecular Biology
- Computational Biology
Background:
- B and T cells undergo V-J recombination to generate antigen receptors.
- Over-representation of a specific V-J rearrangement indicates clonality, crucial for diagnosing lymphoproliferative disorders.
Purpose of the Study:
- To develop objective, automated criteria for classifying B and T cell clonality results.
- To enhance the sensitivity and accuracy of clonality detection using next-generation sequencing (NGS).
Main Methods:
- Developed an NGS-based amplicon clonality assay using clinical samples with established clonality data.
- Created a computational pipeline for automated clonality calling based on a novel reporting model.
- Compared the performance of the developed model against published NGS clonality models.
Main Results:
- The developed NGS model demonstrated increased sensitivity and accuracy in detecting clonality compared to existing methods.
- The automated computational pipeline enables objective and efficient clonality classification.
- The findings suggest improved diagnostic capabilities for lymphoproliferative disorders.
Conclusions:
- The novel NGS-based model and automated pipeline offer a more sensitive and accurate approach to B and T cell clonality assessment.
- This approach has the potential to expedite clinical review and reporting of clonality, aiding in disease management.
- The study provides a robust tool for objective clonality classification in clinical settings.

